Breaking News

Tweet TWEET

Plasma Donors Recognized For Their Lifesaving Contributions To The Treatment Of Rare Diseases

 Plasma Donors Recognized For Their Lifesaving Contributions To The Treatment
                               Of Rare Diseases

CSL Plasma and CSL Behring celebrate International Plasma Awareness Week with
week-long activities and the opening of centers in Texas and Washington

PR Newswire

KING OF PRUSSIA, Pa., Oct. 15, 2013

KING OF PRUSSIA, Pa., Oct. 15, 2013 /PRNewswire/ --CSL Plasma, operator of
one of the largest plasma collection networks in the world and parent company
CSL Behring are celebrating the contributions of donor-heroes during
International Plasma Awareness Week (IPAW), October 13–20.The week-long
observance, which is sponsored by the Plasma Protein Therapeutics Association
and its member companies, raises global awareness of source plasma collection
and increases understanding of plasma protein therapies and rare diseases.

(Logo: http://photos.prnewswire.com/prnh/20100914/PH63692LOGO)

The opening of plasma centers in Vancouver, Washington and Brownsville, Texas
are the latest in CSL Plasma's expansion of its collection network in the West
region. The new centers reflect CSL Plasma and CSL Behring's commitment to
meeting the increasing global demand for plasma and providing quality
therapies to the rare disease community. CSL Plasma operates 82 plasma
centers in the United States and 8 in Germany.

CSL Plasma Senior Vice President and General Manager, Randy Furby, says,
"Plasma that is donated in the collection centers is used to make therapies
that replace missing or deficient proteins that cause rare diseases such as
hemophilia, primary immune deficiencies, hereditary angioedema and inherited
respiratory disease. We view our donors as heroes because without their
contribution, CSL Behring would not be able to provide the lifesaving and
quality of life-enhancing products that our patients rely on."

Lois Lange, a great-grandmother from Idaho, has been on augmentation therapy
for alpha-1 antitrypsin deficiency for the past four years. She is treated
with a CSL Behring product, and is a CSL Behring consumer advocate. Lois says
she's one of the lucky ones because she doesn't have to rely on an oxygen
tank, or be in and out of the hospital with bronchitis and pneumonia.

"Thank God for plasma donors! Without them it would be a lost cause. My
condition is stabilized and I can live life to the fullest, which includes not
only getting to see my grandchildren and great-grandchildren grow up, but
being able to stay active and do things with them. Life is good, and donors
have a lot to do with improving quality of life and life expectancy for people
like me."

CSL Plasma is holding a variety of activities in its centers nationwide during
IPAW to promote greater understanding and appreciation among patients,
employees and donors.CSL Plasma staff is personally thanking donors in the
centers for their time, and emphasizing the impact their donations have on
patients' lives.Other activities focus on educating community and civic
leaders about donors and the economic impact of a plasma center on the
community.CSL Plasma's new center in Vancouver is expected to infuse between
$5 and $6 million directly into the local economy in wages and donor
compensation.

About CSL Behring
CSL Behring is a leader in the plasma protein therapeutics industry. Committed
to saving lives and improving the quality of life for people with rare and
serious diseases, the company manufactures and markets a range of
plasma-derived and recombinant therapies worldwide.

CSL Behring therapies are used around the world to treat coagulation disorders
including hemophilia and von Willebrand disease, primary immune deficiencies,
hereditary angioedema and inherited respiratory disease, and neurological
disorders in certain markets. The company's products are also used in cardiac
surgery, organ transplantation, burn treatment and to prevent hemolytic
diseases in the newborn.

CSL Behring operates one of the world's largest plasma collection networks,
CSL Plasma. CSL Behring is a global biopharmaceutical company and a member of
the CSL Group of companies. The parent company, CSL Limited (ASX: CSL), is
headquartered in Melbourne, Australia. For more information, visit
http://www.cslbehring.com/.

Contact:
Chris Florentz                      Scott Newkirk
CSL Behring                         CSL Plasma
610-878-4316                        561-912-3085
Christopher.Florentz@cslbehring.com Patrick.Newkirk@cslplasma.com

SOURCE CSL Plasma

Website: http://www.cslbehring.com
 
Press spacebar to pause and continue. Press esc to stop.